Two Sigma Investments »

Cerevel Therapeutics Hldng I shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $835k 20k 42.40
2023-09-30 $524k 24k 21.83
2023-06-30 $1.0M 32k 31.79
2023-03-31 $334k 14k 24.39
2022-12-31 $252k 8.0k 31.54

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Rivian Automotive Com Cl A Put Option (RIVN)
Carnival Corp Unit 99/99/9999 (CCL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Netflix (NFLX)
Apple (AAPL)
Visa Com Cl A (V)
Paypal Holdings (PYPL)
Pinterest Cl A (PINS)
Alphabet Cap Stk Cl A (GOOGL)
American Airls Put Option (AAL)
Bristol Myers Squibb (BMY)

View all positions for Two Sigma Investments

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I